Shifting pipelines drive AMRI to expand protein expression services
AMRI has added protein expression and purification services to its drug discovery services citing the shift in pipelines towards larger molecule drugs as a driver.
Archives for September 4, 2014
CMC Biologics to manufacture Zymeworks antibody
Contract manufacturer CMC Biologics and Zymeworks have entered into a master services agreement whereby CMC will perform the process development, formulation development and cGMP clinical manufacturing of a recombinant human IgG1 bi-specific...
NICE result for Soliris, but no justification for high manufacturing costs
The monoclonal antibody drug Soliris has been recommended by NICE despite Alexion failing to justify the manufacturing costs contributing to the £3,150 ($5,140) price per vial.
Vaccine industry poised for rapid changes in delivery methods, study finds
Over the next five years the vaccine industry will see an influx of transdermal and intradermal delivery systems, as well as other more innovative administration techs, according to a new study from Frost and Sullivan.